KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Divestments (2016 - 2024)

Labcorp Holdings' Divestments history spans 10 years, with the latest figure at -$13.5 million for Q4 2024.

  • For Q4 2024, Divestments rose 45.34% year-over-year to -$13.5 million; the TTM value through Dec 2025 reached -$13.5 million, changed N/A, while the annual FY2023 figure was -$24.7 million, 1643.75% down from the prior year.
  • Divestments for Q4 2024 was -$13.5 million at Labcorp Holdings, down from $13.5 million in the prior quarter.
  • Across five years, Divestments topped out at $13.5 million in Q1 2024 and bottomed at -$24.7 million in Q4 2023.
  • The 5-year median for Divestments is $400000.0 (2022), against an average of -$1.5 million.
  • The largest annual shift saw Divestments skyrocketed 1555.56% in 2021 before it plummeted 2844.44% in 2023.
  • A 5-year view of Divestments shows it stood at $2.1 million in 2020, then crashed by 690.48% to -$12.4 million in 2021, then skyrocketed by 107.26% to $900000.0 in 2022, then tumbled by 2844.44% to -$24.7 million in 2023, then skyrocketed by 45.34% to -$13.5 million in 2024.
  • Per Business Quant, the three most recent readings for LH's Divestments are -$13.5 million (Q4 2024), $13.5 million (Q1 2024), and -$24.7 million (Q4 2023).